by | PRNewswire Asia
TAIPEI, Oct. 14, 2025 /PRNewswire/ — GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-TKI, a novel multi-receptor tyrosine kinase inhibitor for cancer immunotherapy. GNTbm-TKI will be presented as posters at the 2025 European...
by | PRNewswire Asia
Hang Seng Biotech Index Futures to launch on 28 November 2025 New futures contracts offer risk management tools for one of the fastest growing sectors in Hong Kong capital markets SFC Transaction Levy Exemption will be applied for the first six months from launch...
by | PRNewswire Asia
BANGKOK, Oct. 14, 2025 /PRNewswire/ — A student team from Nutrinex, Department of Food Technology, Faculty of Science, Chulalongkorn University, has developed "Pork Knuckle Trio"—a nutritious alternative to traditional braised pork leg....
by | PRNewswire Asia
SINGAPORE, Oct. 14, 2025 /PRNewswire/ — PRC-Saltillo, a leading provider of AAC (Augmentative and Alternative Communication) devices and support services, is proud to announce the official launch of its wholly owned subsidiary, PRC...
by | PRNewswire Asia
HONG KONG, Oct. 13, 2025 /PRNewswire/ — In a major development for China’s cosmetic industry, CHANDO Group, a leading homegrown cosmetics brand, has completed a new round of financing. Harvest Capital has invested ¥300 million (over US$40 million) in...
by | PRNewswire Asia
RESORB Study Marks Major Step Toward U.S. Regulatory Approval and Global Commercialization SEOUL, South Korea, Oct. 13, 2025 /PRNewswire/ — NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), an innovative medical device company based in South Korea, today announced the...
